prove precision, but some general principles are known and we can apply calculations of exposure scenarios from that
report. Let’s start with a hypothetical
RTE product inadvertently recontami-nated with only 10 organisms per gram.
Unchecked Listeria growth during refrigerated storage will result in a product
with levels up to log 8–9 colony-forming
units per gram (i.e., 100 million–1 billion organisms per gram) within 3 to 4
weeks. Then, if a pregnant woman were
to consume two ounces of the product
at that point, her risk of a miscarriage
could be around one in 7,500. This is a
serious risk. If the same product is formulated to inhibit Listeria growth to 1
or 2 logs, that is, the numbers of Listeria
would be limited to 100 to 1,000 per
gram, then the risk profile decreases to
between one in 75 million and one in 50
billion. It is this significant risk reduction that led many companies to add
lactate and diacetate to their formulations (Figure 1).
on environmental controls to prevent recontamination after processing. Alternative 2 adds either a growth inhibitor
ingredient in the RTE product or a post-packaging treatment that is validated to
reduce the number of Listeria. Alternative 1 represents the use of both a
growth inhibitor and a post-package
treatment. The regulations also describe
regulatory consequences of finding
Listeria on food contact surfaces in the processing facility with differences for each
alternative with respect to finished product sampling. Alternative 1 and 2 systems offer manufacturers a little more
regulatory flexibility because they have
the safety extra hurdles in place.
Since the development of lactate and
diacetate to inhibit Listeria growth was
commercialized, there have been many
other ingredients introduced that have
enlarged the array of choices for processors. These include blends of organic
acid salts and other natural fermentation
products, bacteriocins, phages, some
WE PROTECT
PRODUCTS &
REPUTATIONS
Innovators in
Food Safety
& Marination
{ Let us show you how to }
Another reason for the widespread
use of growth-inhibiting ingredients was
the USDA rule issued on an interim
basis in late 2003 and finalized in 2005.
It specified three regulatory options to
address L. monocytogenes risk for RTE
meat and poultry products. These can
be found in 9CFR430.4. The options ac-
knowledge the multiple hurdle mental-
ity, but the regulatory numbering system
is the opposite of the number of Listeria
hurdles. An Alternative 3 system relies
natural antioxidants and other ingredi-
ents. A list of approved substances with
their labeling requirements is found in
USDA – Food Safety and Inspection
Service’s (FSIS) directive 7120.1, which
can be accessed at
www.fsis.usda.gov/Regulations_&_
Policies/7000_Series-Processed_
Products/ index.asp.
How effective have all these approaches been? Before FSIS published
the proposed rule, the FDA and Centers
Figure 1: FDA Risk Analysis: Counts vs. Mortality
r;*OIJCJU;QBUIPHFO;PVUHSPXUI;
r;&YUFOE;QSPEVDU;TIFMG;MJGF;
;r;3FEVDF;TPEJVN;DPOUFOU;
r;&OIBODF;QSPEVDU;óBWPS;
;r;*ODSFBTF;ZJFMET;
Call us at 877-758-1745